Global Presence

International Operations


View Products

Getz Pharma started marketing products in Sudan in 2008, With a strong marketing strategy, well-educated and highly trained team and patient centric approach, Getz Pharma has achieved rapid growth in Sudan.

In Sudan, Getz Pharma products span the following therapeutic segments:

  • Anti – Asthmatic
  • Anti – Convulsant
  • Anti – Diabetic
  • Anti – Lipidemic
  • Anti – Rheumatic

Getz Pharma pioneered Pregabalin (Gabica) and Rosuvastatin (Rovista) in Sudan, and is a market leader in these segments. Similarly, Glimepiride (Getryl), Montelukast (Montiget) and Hydroxychloroquine (HCQ) are also market leaders in their respective fields.